Lumefantrine, a vital antimalarial drug typically used in combination with artemether for the treatment of Plasmodium falciparum malaria, represents a significant segment of the global pharmaceutical trade. As malaria remains a persistent public health challenge in endemic regions worldwide, the demand for lumefantrine-based combination therapies continues to grow steadily. For suppliers, manufacturers, and exporters, understanding the landscape of global buyers is essential for market penetration and sustainable business growth. The global lumefantrine trade ecosystem encompasses 2,231 verified buyers across 112 importing countries, supplied by 596 suppliers from 35 exporting nations. This comprehensive guide provides actionable intelligence on the world’s leading lumefantrine buyers, market dynamics, and procurement channels. Global Lumefantrine Market Overview The lumefantrine market is experiencing…